June 18, 2026
4m 25s
Share:
Biobarica Talk — Episode 27 Interviewer: Dr. Fabrizio Verdini, Biobarica Medical Liaison
There is a question many medical centers ask themselves before incorporating hyperbaric therapy: will there be enough demand to sustain the service? Samantha Gutiérrez, Biobarica's authorized distributor and operational representative in Mexico, has spent six years answering that question from the field. And her answer, built on one of Biobarica's most successful networks globally, is unambiguous: in Mexico, it is the patients themselves who are asking for hyperbaric therapy. The model is already validated. The key is implementing it in full.
Six Years Building Biobarica's Most Successful Network in Mexico
Samantha Gutiérrez took the lead on the Biobarica Mexico project in 2020, although the family relationship with the company dates back to 2016. Over these six years, she has been both witness and protagonist of the growth of hyperbaric medicine in a market as diverse and demanding as Mexico.
When Dr. Fabrizio Verdini asks what the main differentiator of the Biobarica solution is in Mexico, her answer goes straight to the core of what makes this technology distinct:
"The biggest difference with Biobarica is that it managed to turn a therapy that was historically complex into an accessible, viable therapy for centers — to make something complex into something accessible."
That transformation — from complex to accessible — is not rhetorical. It is the result of a product design, a support ecosystem, and an implementation model that removed the barriers that had historically made it difficult to incorporate hyperbaric oxygen therapy into a conventional medical practice.
The Two Variables Centers Value Most: Operability and Patient Experience
When asked what centers value most about the Biobarica solution in their day-to-day operations, Samantha does not hesitate:
"There are two: one is operational ease and the other is the client experience."
The operational ease of the Revitalair hyperbaric chamber translates into concrete terms: easy installation, low operating costs, straightforward training, and technology that does not require highly specialized staff. But it is the second variable — the patient experience — where Samantha goes into greater depth:
"When a person generally hears 'hyperbaric chamber,' they generally feel intimidated. The main difference I notice is this: having a wider, more comfortable cabin, where they can lie down, get comfortable, bring their devices... that creates adherence to the therapy, and when there is adherence to the therapy, therapeutic efficacy is achieved."
This point is strategically central. Hyperbaric therapy only works when the protocol is completed. And a protocol is only completed when the patient wants to come back. The experience inside the chamber — comfortable, non-intimidating, with air pressurization that maintains therapeutic efficacy without the elements that generate rejection — is what turns patients into adherents and, afterward, into promoters.
The BGS: Much More Than an Administrative Tool
One of the richest exchanges in the interview concerns the Biobarica Global System — the integrated management software that comes with every unit — and the value Samantha assigns to it beyond its operational function.
"The BGS, more than being an administrative tool, is a service professionalization tool. From day one, without any prior knowledge of the therapy or its implementation, you already have tools to get certified, trained, to implement the service — and not start from scratch."
Samantha clearly distinguishes the stages at which centers make use of the BGS:
In the initial stage, centers prioritize certifications and training, and access to ready-to-use materials that allow them to launch the service as a business model from day one.
In a more advanced stage, the use of the scheduling system, patient follow-up, and analysis of therapeutic progress generate professionalization, standardization, and above all, patient safety.
But there is one dimension of the BGS that Samantha values especially — one that goes beyond the individual management of each center:
"It is a tool that generates collective information that supports the development of hyperbaric medicine itself. All the statistics, the data that help you analyze the progress of the therapy across different conditions... it is part of helping the therapy grow and take it further."
The Business Model That Grows on Its Own, When Implemented in Full
The most revealing part of the interview comes when Samantha describes the pattern she observes in the centers that grow most within the Biobarica network in Mexico:
"The clients who have acquired a second or third unit are precisely those who implemented the complete model. Growth is a consequence."
The logic is circular and self-reinforcing: trained staff who understand the therapy → patient who receives a clear explanation → comfortable experience inside the chamber → adherence to the protocol → therapeutic results → recommendation → more patients → need to scale.
None of those links works in isolation. The chamber without the BGS is hardware. The BGS without training is unused software. Training without a device the patient tolerates is theory without results. It is the integration of all components — equipment, software, protocols, support — that activates the model.
The Question the Market Asks Most: Will There Be Enough Demand?
Samantha identifies with precision the real barrier that holds back centers that have not yet taken the step:
"The uncertainty clients feel when questioning whether or not to make the investment is not so much doubt about the technology — it is doubt about whether they will have enough demand to sustain the service."
And her answer, built from six years in the Mexican market, is direct:
"I have clients who tell me: 'I'm not sure how the hyperbaric chamber works, but patients are already asking for it.' That is what gives me the peace of mind to know that the model is completely viable."
In Mexico, the spread of hyperbaric therapy was not driven by marketing. It was driven by satisfied patients. That is the most solid signal a market can give about a technology: when demand generates itself, the model is already validated.
Conclusion: Trust the Process, Implement It in Full
What Samantha Gutiérrez describes from Mexico is not just the testimony of a successful distributor. It is the map of a model that works when respected in its entirety: accessible equipment, carefully managed patient experience, BGS implemented, standardized protocols, and support available at every stage.
Six years, a constantly growing network, and centers that come back to purchase their second and third unit. Those are the numbers that speak for themselves.
If you are a physician, clinic, or investor and want to learn how to implement the Biobarica solution in your center, contact our team and a specialist will guide you from the very first step.
Watch de full interview here
Biobarica Talk, Episode 27. Interviewer: Dr. Fabrizio Verdini, Biobarica Medical Liaison.
Share:
Related
